Replies to post #235851 on Biotech Values

[DewDiligence]

RVNC PR on manufacturing-inspection delay due to COVID:

https://investors.revance.com/news-releases/news-release-details/fda-defers-approval-daxibotulinumtoxina-injection-glabellar

Note: RVNC did not receive a CRL.